Florida Pharmaceutical Products

Florida Pharmaceutical Products (FPP) is a Boca Raton-based pharmaceutical company specializing in the development, licensing, and distribution of generic prescription medications. Founded in 1999, the company focuses on niche generic products across a wide range of therapeutic areas, including oncology, metabolic diseases, and anti-infectives. FPP operates through a network of strategic partnerships for R&D and manufacturing, managing the sales, marketing, and distribution of its portfolio in the United States. In June 2023, the company was acquired by Indoco Remedies, an Indian pharmaceutical firm, to strengthen its presence in the U.S. market. The company's portfolio includes several approved ANDAs for treatments such as abiraterone acetate and tenofovir.